At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
In Brief
A Phase 2 clinical trial evaluating 200mg IV thiamine in 50mL 0.9% saline and Placebo for Diabetic Ketoacidosis. Completed, enrolled 102 participants across 1 site.
Detailed Summary
This is a randomized, double-blind, placebo-controlled trial to determine if administration of intravenous thiamine will lead to quicker resolution of acidosis in patients admitted to the hospital with diabetic ketoacidosis. The investigators will secondarily investigate whether thiamine improves cellular oxygen consumption, shortens intensive care unit (ICU) and hospital stay or decreases hospital resource utilization.
Study Details
Timeline
Arms & Interventions
200mg IV thiamine in 50mL 0.9% saline twice daily for 2 days
100mL 0.9% saline twice daily for two days
Interventions
Thiamine 200mg IV every 12 hours for 2 days
50mL 0.9% saline